The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from government-funded contracts and authorize the Trump administration to bar US ...

Dec 10 (Reuters) - French biotech company Abivax's (ABVX.PA), opens new tab shares rose by over 20% on Wednesday on market rumours that U.S. pharma giant Eli Lilly (LLY.N), opens new tab could make an ...

HPBOSE 12th Date Sheet 2026: The Himachal Pradesh Board of School Education (HPBOSE) has officially released the HPBOSE 12th Date Sheet 2026 on November 26, 2025, through its website hpbose.org. As ...

Canada has a solid showing in health sciences and biotech, when it comes to innovation and startups. But how can we turn that into a mature and thriving sector? Amanda Lang speaks with Gordon McCauley ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Bihar Board 12th Time Table PDF: The Bihar School Examination Board (BSEB) has released the Bihar Board 12th Exam Date 2026 for Arts, Science, and Commerce streams. The official BSEB Class 12 time ...

SHANGHAI, Dec 5 (Reuters) - China's Sichuan Kelun-Biotech Biopharmaceutical (6990.HK) said Thursday night, opens new tab it would license an experimental cancer treatment out to U.S. drugmaker ...

Akebia Therapeutics has struck a deal for Q32 Bio’s deprioritized complement inhibitor ADX-097, paying $7 million upfront for an asset that forms the centerpiece of its new rare kidney disease ...

Saluda Medical will list on the ASX this week after raising more than $230 million to drive sales growth for its pain relief device. Saluda Medical raised $231 million in its initial public offer. The ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Austin-based Natera is expanding ...

ORLANDO, Fla.—The leader of Gilead Sciences' Kite Pharma is sure that anito-cel, the biotech’s next-generation multiple myeloma CAR-T challenger to Carvykti, is ready for prime time—and that the ...